VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,093,000 | +19.8% | 28,500 | 0.0% | 1.52% | +38.9% |
| Q4 2021 | $912,000 | +8.7% | 28,500 | 0.0% | 1.10% | -30.2% |
| Q3 2021 | $839,000 | -13.3% | 28,500 | 0.0% | 1.57% | -9.8% |
| Q2 2021 | $968,000 | -59.5% | 28,500 | -58.8% | 1.74% | -29.3% |
| Q1 2021 | $2,392,000 | +63.2% | 69,195 | +70.0% | 2.46% | -17.2% |
| Q4 2020 | $1,466,000 | -8.0% | 40,695 | 0.0% | 2.98% | -22.5% |
| Q3 2020 | $1,594,000 | -14.2% | 40,695 | -19.7% | 3.84% | -5.7% |
| Q2 2020 | $1,858,000 | +1.3% | 50,660 | -36.4% | 4.07% | +18.2% |
| Q1 2020 | $1,834,000 | -37.1% | 79,610 | -20.1% | 3.45% | +12.7% |
| Q4 2019 | $2,917,000 | +0.6% | 99,610 | -8.3% | 3.06% | -4.3% |
| Q3 2019 | $2,901,000 | +0.1% | 108,610 | -4.2% | 3.19% | -1.8% |
| Q2 2019 | $2,897,000 | +12.7% | 113,350 | -1.1% | 3.25% | +7.9% |
| Q1 2019 | $2,571,000 | +4.7% | 114,660 | -1.5% | 3.01% | -5.4% |
| Q4 2018 | $2,455,000 | – | 116,385 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |